Armata Pharmaceuticals (ARMP) Enterprise Value (2016 - 2018)
Armata Pharmaceuticals (ARMP) has disclosed Enterprise Value for 6 consecutive years, with -$13.4 million as the latest value for Q3 2018.
- Quarterly Enterprise Value fell 73.37% to -$13.4 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was -$13.4 million through Sep 2018, down 73.37% year-over-year, with the annual reading at -$5.1 million for FY2017, 0.0% changed from the prior year.
- Enterprise Value hit -$13.4 million in Q3 2018 for Armata Pharmaceuticals, up from -$15.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$2.2 million in Q1 2017 to a low of -$16.6 million in Q1 2015.
- Historically, Enterprise Value has averaged -$9.5 million across 5 years, with a median of -$9.0 million in 2017.
- Biggest YoY gain for Enterprise Value was 67.67% in 2014; the steepest drop was 2185.81% in 2014.
- Year by year, Enterprise Value stood at -$6.6 million in 2014, then crashed by 42.38% to -$9.4 million in 2015, then surged by 45.23% to -$5.1 million in 2016, then changed by 0.0% to -$5.1 million in 2017, then plummeted by 160.97% to -$13.4 million in 2018.
- Business Quant data shows Enterprise Value for ARMP at -$13.4 million in Q3 2018, -$15.4 million in Q2 2018, and -$8.2 million in Q1 2018.